World Epigenetics Market - Opportunities and Forecasts, 2014 - 2022

  • ID: 3773364
  • Report
  • Region: Global
  • 185 pages
  • Allied Analytics LLP
1 of 7

FEATURED COMPANIES

  • Abcam
  • Active Motif
  • Diagenode
  • Illumina
  • Merck
  • New England Biolabs
  • MORE
Epigenetics is a stream of genetics that involves the study of cellular and physiological trait variations initiated by external or ecological aspects, which turn genes on and off and affect the cellular ability to read genes without being affected by changes in the genotype Epigenetics results into changes in the organisms’ phenotype rather than the genotype, wherein the underlying DNA or RNA sequence remains unchanged. The global epigenetics market accounted for $555 million in 2016, and is estimated to reach at $1,321 million by 2023, registering a CAGR of 13.1% from 2017 to 2023.

Epigenetic alterations are essential for development; they are dynamic and change with respect to the environmental stimuli. However, these changes can also be stable and could be passed on from one generation to another. Biology and genetic expressions of most organisms are affected by epigenetics, thereby making it one of the most crucial fields of developmental genetics and molecular biology.

High incidence of cancer; increase in R&D activities; surge in investments funding, rise in epigenetic applications for non-oncology diseases; and growth in partnership between academic, pharmaceutical, and biotechnology companies cumulatively supplement the growth of the global epigenetics market. However, high cost of instruments and lack of trained professionals impede the growth of this market. Furthermore, untapped potential of emerging markets provides lucrative opportunities to the market players.

The epigenetics market is segmented based on product, application, end user, and geography. Based on product, it is divided into enzymes, kits & assays, instruments, and reagents. Enzymes are further classified into DNA ligases, DNA polymerases, other DNA-modifying enzymes, acetylases, methyltransferases, other protein-modifying enzymes, reverse transcriptase, RNA ligases, and other RNA-modifying enzymes. Kits & assays are further subdivided into bisulfite conversion kits, chip-seq kits, deep sequencing kits, methyltransferase assays, histone assays, immunoprecipitation kits & other epigenetic kits. Based on instruments, the market is further sub segmented into mass spectrometers, next-generation sequencers, qPCRs, and sonicators & other instruments. Reagents are further divided into antibodies, buffers, histones, magnetic beads, primers, and other epigenetics reagents.

On the basis application, the market is classified into oncology and non-oncology. Oncology is further sub segmented into solid tumors & liquid tumors. Non-oncology applications include inflammatory diseases, metabolic diseases, infectious diseases, cardiovascular diseases, developmental biology, drug discovery, and other applications. On the basis of end user, the market is classified into academic & research institutes, pharmaceutical companies, biotechnology companies, and contract research organizations (CROs). Geographically, it is analyzed based on four regions, namely, North America, Europe, Asia-Pacific, and LAMEA.

KEY MARKET BENEFITS FOR STAKEHOLDERS

The study provides an in-depth analysis of the global epigenetics market and the current trends and future estimations to elucidate the imminent investment pockets.
It presents a quantitative analysis of the market from 2016 to 2023 to enable stakeholders to capitalize on the prevailing market opportunities.
Extensive analysis of the market based on application assists to understand the trends in the industry.
Key market players and their strategies are thoroughly analyzed to understand the competitive outlook of the market.

KEY PLAYERS PROFILED

Abcam plc.
Illumina
QIAGEN N.V.
Epizyme, Inc.
New England Biolabs, Inc.
Merck & Co.,
Thermo Fisher Scientific, Inc.
Active Motif,
Diagenode, Inc.
Zymo Research Corporation

KEY MARKET SEGMENTS

By Product

Enzymes
DNA Ligases
DNA Polymerases
Other DNA-modifying Enzymes
Acetylases
Methyltransferases
Other Protein-modifying Enzymes
Reverse Transcriptase
RNA Ligases
Other RNA-modifying Enzymes
Kits & Assays
Bisulfite Conversion Kits
Chip-seq Kits
Deep Sequencing Kits
Methyltransferase Assays
Histone Assays
Immunoprecipitation Kits
Other Epigenetic Kits
Instruments
Mass Spectrometers
Next-generation Sequencers
qPCRs
Sonicators
Other Instruments
Reagents
Antibodies
Buffers
Histones
Magnetic Beads
Primers
Other Epigenetics Reagents

By Application

Oncology
Solid Tumors
Liquid Tumors
Non-oncology
Inflammatory Diseases
Metabolic Diseases
Infectious Diseases
Cardiovascular Diseases
Developmental Biology
Drug Discovery
Others

By End User

Academic & Research Institutes
Pharmaceutical Companies
Biotechnology Companies
Contract Research Organizations (CROs)

By Geography

North America
U.S.
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
Australia
India
South Korea
Taiwan
Rest of Asia-Pacific
LAMEA
Brazil
Turkey
Saudi Arabia
South Africa
Rest of LAMEA

The other players in the value chain include (profiles not included in the report)

Domainex
CellCentric Ltd.
Chroma Therapeutics Ltd.
Eisai Co. Ltd.
Novartis International AG
Oncolys Biopharma Inc.
Syndax Pharmaceuticals, Inc.
Valirx plc.
READ MORE
Note: Product cover images may vary from those shown
2 of 7

FEATURED COMPANIES

  • Abcam
  • Active Motif
  • Diagenode
  • Illumina
  • Merck
  • New England Biolabs
  • MORE
CHAPTER 1 INTRODUCTION
1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models

CHAPTER 2 EXECUTIVE SUMMARY
2.1. CXO PERSPECTIVE

CHAPTER 3 MARKET OVERVIEW
3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. TOP PLAYER POSITIONING
3.4. PATENTS ANALYSIS
3.4.1. Patent analysis by year
3.4.2. Patent analysis by region
3.5. PORTERS FIVE FORCES ANALYSIS
3.6. MARKET DYNAMICS
3.6.1. Drivers
3.6.2. Restraints
3.6.3. Opportunities

CHAPTER 4 GLOBAL EPIGENETICS MARKET, BY PRODUCT
4.1. OVERVIEW
4.1.1. Market size & forecast
4.2. KITS
4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size & forecast
4.2.4. ChIP sequencing Kits
4.2.4.1. Market size and forecast
4.2.5. Bisulfite conversion kits
4.2.5.1. Market size and forecast
4.2.6. Whole genome amplification kits
4.2.6.1. Market size and forecast
4.2.7. 5-hmC & 5-mC analysis kits
4.2.7.1. Market size and forecast
4.2.8. RNA sequencing kits
4.2.8.1. Market size and forecast
4.2.9. Other epigenetics kits
4.2.9.1. Market size and forecast
4.3. REAGENTS
4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size & forecast
4.3.4. Antibodies
4.3.4.1. Market size and forecast
4.3.5. Magnetic beads
4.3.5.1. Market size and forecast
4.3.6. Histones
4.3.6.1. Market size and forecast
4.3.7. Buffers
4.3.7.1. Market size and forecast
4.3.8. Primers
4.3.8.1. Market size and forecast
4.3.9. Other epigenetics reagents
4.3.9.1. Market size and forecast
4.4. ENZYMES
4.4.1. Key market trends
4.4.2. Growth factors and opportunities
4.4.3. Market size & forecast
4.4.4. DNA Polymerase
4.4.4.1. Market size and forecast
4.4.5. Other DNA-modifying enzymes
4.4.5.1. Market size and forecast
4.4.6. DNA ligase
4.4.6.1. Market size and forecast
4.4.7. Methyltransferase
4.4.7.1. Market size and forecast
4.4.8. Acetylase
4.4.8.1. Market size and forecast
4.4.9. Reverse transcriptase
4.4.9.1. Market size and forecast
4.4.10. Other protein-modifying enzymes
4.4.10.1. Market size and forecast
4.4.11. RNA ligase
4.4.11.1. Market size and forecast
4.4.12. Other RNA-modifying enzymes
4.4.12.1. Market size and forecast
4.5. INSTRUMENTS
4.5.1. Key market trends
4.5.2. Growth factors and opportunities
4.5.3. Market size & forecast
4.5.4. Next generation sequencer
4.5.4.1. Market size and forecast
4.5.5. qPCR
4.5.5.1. Market size and forecast
4.5.6. Mass spectrometer
4.5.6.1. Market size and forecast
4.5.7. Sonicator
4.5.7.1. Market size and forecast
4.5.8. Other instruments
4.5.8.1. Market size and forecast

CHAPTER 5 ENERGY EPIGENETICS MARKET, BY APPLICATION
5.1. OVERVIEW
5.1.1. Market size & forecast
5.2. ONCOLOGY
5.2.1. Market size & forecast
5.2.1. Solid tumor
5.2.1.1. Market size and forecast
5.2.2. Liquid tumor
5.2.2.1. Market size and forecast
5.3. NON-ONCOLOGY
5.3.1. Market size & forecast
5.3.2. Metabolic disease
5.3.2.1. Market size and forecast
5.3.3. Infectious disease
5.3.3.1. Market size and forecast
5.3.4. Inflammatory disease
5.3.4.1. Market size and forecast
5.3.5. Cardiovascular disease
5.3.5.1. Market size and forecast
5.3.6. Other applications
5.3.6.1. Market size and forecast

CHAPTER 6 GLOBAL EPIGENETICS MARKET, BY END USERS
6.1. OVERVIEW
6.1.1. Market size & forecast
6.2. ACADEMIC & GOVERNMENT RESEARCH INSTITUTE
6.2.1. Market size & forecast
6.3. PHARMACEUTICAL COMPANY
6.3.1. Market size & forecast
6.4. BIOTECHNOLOGY COMPANY
6.4.1. Market size & forecast
6.5. CONTRACT RESEARCH ORGANIZATION (CRO)
6.5.1. Market size & forecast

CHAPTER 7 EPIGENETICS MARKET, BY GEOGRAPHY
7.1. OVERVIEW
7.2. NORTH AMERICA
7.2.1. Key market trends
7.2.2. Key growth factors and opportunities
7.2.3. Market size & forecast
7.2.3.1. U.S. market size and forecast
7.2.3.2. Canada market size and forecast
7.2.3.3. Mexico market size and forecast
7.3. EUROPE
7.3.1. Key market trends
7.3.2. Key growth factors and opportunities
7.3.3. Market size & forecast
7.3.3.1. Germany market size and forecast
7.3.3.2. France market size and forecast
7.3.3.3. UK market size and forecast
7.3.3.4. Italy market size and forecast
7.3.3.5. Spain market size and forecast
7.3.3.6. Rest of Europe market size and forecast
7.4. ASIA-PACIFIC
7.4.1. Key market trends
7.4.2. Key growth factors and opportunities
7.4.3. Market size & forecast
7.4.3.1. Japan market size and forecast
7.4.3.2. China market size and forecast
7.4.3.3. Australia market size and forecast
7.4.3.4. India market size and forecast
7.4.3.5. South Korea market size and forecast
7.4.3.6. Taiwan market size and forecast
7.4.3.7. Rest of Asia-Pacific market size and forecast
7.5. LAMEA
7.5.1. Key market trends
7.5.2. Key growth factors and opportunities
7.5.3. Market size & forecast
7.5.3.1. Brazil market size and forecast
7.5.3.2. Turkey market size and forecast
7.5.3.3. Saudi Arabia market size and forecast
7.5.3.4. Rest of LAMEA market size and forecast

CHAPTER 8 COMPANY PROFILES
8.1. ILLUMINA, INC
8.1.1. Operating business segments
8.1.2. Business performance
8.2. THERMO FISHER SCIENTIFIC, INC
8.2.1. Operating business segments
8.2.2. Business performance
8.2.3. Key strategic moves and developments
8.3. ABCAM PLC
8.3.1. Operating business segments
8.3.2. Business performance
8.3.3. Key strategic moves and developments
8.4. EPIZYME, INC.
8.4.1. Operating business segments
8.4.2. Business performance
8.4.3. Key strategic moves and developments
8.5. NEW ENGLAND BIOLABS, INC. (NEB)
8.5.1. Operating business segments
8.5.2. Business performance
8.5.3. Key strategic moves and developments
8.6. QIAGEN N.V.,
8.6.1. Operating business segments
8.6.2. Business performance
8.6.3. Key strategic moves and developments
8.7. MERCK & CO., (MERCK)
8.7.1. Operating business segments
8.7.2. Business performance
8.7.3. Key strategic moves and developments
8.8. ACTIVE MOTIF
8.8.1. Operating business segments
8.8.2. Business performance
8.8.3. Key strategic moves and developments
8.9. DIAGENODE, INC.
8.9.1. Operating business segments
8.9.2. Business performance
8.9.3. Key strategic moves and developments
8.10. ZYMO RESEARCH CORPORATION (ZYMO)
8.10.1. Operating business segments
8.10.2. Business performance
8.10.3. Key strategic moves and developments

List of Tables
Table 1. Global Epigenetics Market, By Product, 2016-2023 ($Million)
Table 2. Global Epigenetics Kits Market, By Product Type, 2016-2023 ($Million)
Table 3. Epigenetics Chip Sequencing Kits Market, By Region, 2016-2023 ($Million)
Table 4. Epigenetics Bisulfite Conversion Kits Market, By Region, 2016-2023 ($Million)
Table 5. Epigenetics Whole Genome Amplification Kits Market, By Region, 2016-2023 ($Million)
Table 6. Epigenetics 5-Hmc & H-Mc Analysis Kits Market, By Region, 2016-2023 ($Million)
Table 7. Epigenetics Rna Sequencing Kits Market, By Region, 2016-2023 ($Million)
Table 8. Other Epigenetics Kits Market, By Region, 2016-2023 ($Million)
Table 9. Global Epigenetics Reagents Market, By Product Type, 2016-2023 ($Million)
Table 10. Epigenetics Antibodies Market, By Region, 2016-2023 ($Million)
Table 11. Epigenetics Magnetic Beads Market, By Region, 2016-2023 ($Million)
Table 12. Epigenetics Histones Market, By Region, 2016-2023 ($Million)
Table 13. Epigenetics Buffers Market, By Region, 2016-2023 ($Million)
Table 14. Epigenetics Primers Market, By Region, 2016-2023 ($Million)
Table 15. Other Epigenetics Reagents Market, By Region, 2016-2023 ($Million)
Table 16. Global Epigenetics Enzymes Market, By Product Type, 2016-2023 ($Million)
Table 17. Epigenetics Dna Polymerase Market, By Region, 2016-2023 ($Million)
Table 18. Epigenetics Other Dna Modifying Enzymes Market, By Region, 2016-2023 ($Million)
Table 19. Epigenetics Dna Ligase Market, By Region, 2016-2023 ($Million)
Table 20. Epigenetics Methyltransferase Market, By Region, 2016-2023 ($Million)
Table 21. Epigenetics Acetylase Market, By Region, 2016-2023 ($Million)
Table 22. Epigenetics Reverse Transcriptase Market, By Region, 2016-2023 ($Million)
Table 23. Epigenetics Other Protein-Modifying Enzymes Market, By Region, 2016-2023 ($Million)
Table 24. Epigenetics Rna Ligase Market, By Region, 2016-2023 ($Million)
Table 25. Epigenetics Other Rna Modifying Enzymes Enzymes Market, By Region, 2016-2023 ($Million)
Table 26. Global Epigenetics Instruments Market, By Product Type, 2016-2023 ($Million)
Table 27. Epigenetics Next Generation Sequencer Market, By Region, 2016-2023 ($Million)
Table 28. Epigenetics Qpcr Market, By Region, 2016-2023 ($Million)
Table 29. Epigenetics Mass Spectrometer Market, By Region, 2016-2023 ($Million)
Table 30. Epigenetics Sonicator Market, By Region, 2016-2023 ($Million)
Table 31. Epigeneticsother Instruments Market, By Region, 2016-2023 ($Million)
Table 32. Global Epigenetics Market, By Application, 2016-2023 ($Million)
Table 33. Global Oncology Epigenetics Market, By Application Type, 2016-2023 ($Million)
Table 34. Epigenetics Solid Tumor Market, By Region, 2016-2023 ($Million)
Table 35. Epigenetics Liquid Tumor Market, By Region, 2016-2023 ($Million)
Table 36. Global Non-Oncology Epigenetics Market, By Application, 2016-2023 ($Million)
Table 37. Epigenetics Metabolic Disease Market, By Region, 2016-2023 ($Million)
Table 38. Epigenetics Infectious Disease Market, By Region, 2016-2023 ($Million)
Table 39. Epigenetics Inflammatory Disease Market, By Region, 2016-2023 ($Million)
Table 40. Epigenetics Cardiovascular Disease Market, By Region, 2016-2023 ($Million)
Table 41. Epigenetics Other Application Market, By Region, 2016-2023 ($Million)
Table 42. Global Epigenetics Market, By End USers, 2016-2023 ($Million)
Table 43. Academic & Government Research Institute Epigenetics Market, By Region, 2016-2023 ($Million)
Table 44. Pharmaceutical Company Epigenetics Market, By Region, 2016-2023 ($Million)
Table 45. Biotechnology Company Epigenetics Market, By Region, 2016-2023 ($Million)
Table 46. Cro Epigenetics Market, By Region, 2016-2023 ($Million)
Table 69. Asia-Pacific Epigenetics Market, By Country, 2016-2023 ($Million)
Table 70. Asia-Pacific Epigenetics Market, By Product, 2016-2023 ($Million)
Table 71. Asia-Pacific Epigenetics Kits Market, By Product Type, 2016-2023 ($Million)
Table 72. Asia-Pacific Epigenetics Reagents Market, By Product Type, 2016-2023 ($Million)
Table 73. Asia-Pacific Epigenetics Enzymes Market, By Product Type, 2016-2023 ($Million)
Table 74. Asia-Pacific Epigenetics Instruments Market, By Product Type, 2016-2023 ($Million)
Table 75. Asia-Pacific Epigenetics Market, By Application, 2016-2023 ($Million)
Table 76. Asia-Pacific Oncology Epigenetics Market, By Application Type, 2016-2023 ($Million)
Table 77. Asia-Pacific Non-Oncology Epigenetics Market, By Application Type, 2016-2023 ($Million)
Table 79. Lamea Epigenetics Market, By Country, 2016-2023 ($Million)
Table 80. Lamea Epigenetics Market, By Product, 2016-2023 ($Million)
Table 81. Lamea Epigenetics Kits Market, By Product Type, 2016-2023 ($Million)
Table 82. Lamea Epigenetics Reagents Market, By Product Type, 2016-2023 ($Million)
Table 83. Lamea Epigenetics Enzymes Market, By Product Type, 2016-2023 ($Million)
Table 84. Lamea Epigenetics Instruments Market, By Product Type, 2016-2023 ($Million)
Table 85. Lamea Epigenetics Market, By Application, 2016-2023 ($Million)
Table 86. Lamea Oncology Epigenetics Market, By Application Type, 2016-2023 ($Million)
Table 87. Lamea Non-Oncology Epigenetics Market, By Application Type, 2016-2023 ($Million)
Table 89. Illumina, Inc: Company Snapshot
Table 90. Thermo Fisher Scientific, Inc: Company Snapshot
Table 91. Abcam Plc: Company Snapshot
Table 92. Epizyme, Inc.: Company Snapshot
Table 93. Neb: Company Snapshot
Table 94. Qiagen N.V.: Company Snapshot
Table 95. Merck: Company Snapshot
Table 96. Active Motif: Company Snapshot
Table 97. Diagenode, Inc.: Company Snapshot
Table 98. Zymo: Company Snapshot

List of Figures
Figure 1. Epigenetics Market: Market Segmenation
Figure 2. Top Investment Pockets: Global Dna Sequencing Market, By Application
Figure 3. Top Winning Strategies: Nature And Type
Figure 4. Top Winning Strategies: Nature And Company
Figure 5. Top Player Positioning: Global Epigenetics Market
Figure 6. Patent Analysis By Region
Figure 7. Bargaining Power Of Buyers
Figure 8. Bargaining Power Of Suppliers
Figure 9. Threat Of New Entrants
Figure 10. Threat Of Substitution
Figure 11. Competitive Rivalry
Figure 12. Epigenetics Market: Product Segmenation
Figure 13. U.S. Epigenetics Market, 2016-2023 ($Million)
Figure 14. Canada Epigenetics Market, 2016-2023 ($Million)
Figure 15. Mexico Epigenetics Market, 2016-2023 ($Million)
Figure 16. Germany Epigenetics Market, 2016-2023 ($Million)
Figure 17. France Epigenetics Market, 2016-2023 ($Million)
Figure 18. UK Epigenetics Market, 2016-2023 ($Million)
Figure 19. Italy Epigenetics Market, 2016-2023 ($Million)
Figure 20. Spain Epigenetics Market, 2016-2023 ($Million)
Figure 21. Rest Of Europe Epigenetics Market, 2016-2023 ($Million)
Figure 22. Japan Epigenetics Market, 2016-2023 ($Million)
Figure 23. China Epigenetics Market, 2016-2023 ($Million)
Figure 24. Australia Epigenetics Market, 2016-2023 ($Million)
Figure 25. India Epigenetics Market, 2016-2023 ($Million)
Figure 26. South Korea Epigenetics Market, 2016-2023 ($Million)
Figure 27. Taiwan Epigenetics Market, 2016-2023 ($Million)
Figure 28. Rest Of Asia-Pacific Epigenetics Market, 2016-2023 ($Million)
Figure 29. Brazil Epigenetics Market, 2016-2023 ($Million)
Figure 30. Turkey Epigenetics Market, 2016-20223 ($Million)
Figure 31. Saudi Arabia Epigenetics Market, 2016-2023 ($Million)
Figure 32. Rest Of Lamea Epigenetics Market, 2016-2023 ($Million)
Figure 33. Illumina, Inc: Net Sales, 2014-2017 ($Million)
Figure 34. Illumina, Inc: Revenue By Segment, 2015 (%)
Figure 35. Thermo Fisher Scientific, Inc: Net Sales, 2014-2017 ($Million)
Figure 36. Thermo Fisher Scientific, Inc: Revenue By Segment, 2015 (%)
Figure 37. Thermo Fisher Scientific, Inc: Revenue By Geography, 2015 (%)
Figure 38. Abcam Plc: Net Sales, 2014-2017 ($Million)
Figure 39. Abcam Plc.: Revenue By Segment, 2015 (%)
Figure 40. Abcam Plc.: Revenue By Geography, 2015 (%)
Figure 41. Epizyme, Inc.: Net Sales, 2014-2017 ($Million)
Figure 42. Epizyme, Inc.: Revenue By Segment, 2015 (%)
Figure 43. Epizyme, Inc.: Revenue By Geography, 2015 (%)
Figure 44. Neb: Net Sales, 2014-2017 ($Million)
Figure 45. Neb: Revenue By Segment, 2015 (%)
Figure 46. Neb: Revenue By Geography, 2015 (%)
Figure 47. Qiagen N.V: Net Sales, 2014-2017 ($Million)
Figure 48. Qiagen N.V: Revenue By Segment, 2015 (%)
Figure 49. Qiagen N.V: Revenue By Geography, 2015 (%)
Figure 50. Merck: Net Sales, 2014-2017 ($Million)
Figure 51. Merck: Revenue By Segment, 2015 (%)
Figure 52. Merck: Revenue By Geography, 2015 (%)
Figure 53. Active Motif: Net Sales, 2014-2017 ($Million)
Figure 54. Active Motif: Revenue By Segment, 2015 (%)
Figure 55. Active Motif: Revenue By Geography, 2015 (%)
Figure 56. Diagenode, Inc: Net Sales, 2014-2017 ($Million)
Figure 57. Diagenode, Inc: Revenue By Segment, 2015 (%)
Figure 58. Diagenode, Inc: Revenue By Geography, 2015 (%)
Figure 59. Zymo: Net Sales, 2014-2017 ($Million)
Figure 60. Zymo: Revenue By Segment, 2015 (%)
Figure 61. Zymo: Revenue By Geography, 2015 (%)
Note: Product cover images may vary from those shown
3 of 7

Loading
LOADING...

4 of 7

FEATURED COMPANIES

  • Abcam
  • Active Motif
  • Diagenode
  • Illumina
  • Merck
  • New England Biolabs
  • MORE
according to a new report. titled, "Epigenetics Market by Product, Application, and End User: Global Opportunity Analysis and Industry Forecast, 2017-2023," the global epigenetics market was valued at $555 million in 2016, and is projected to reach $1,321 million by 2023, growing at a CAGR of 13.1% from 2017 to 2023. The DNA-modifying enzymes segment witnessed the highest rate, generating maximum revenue in the market in 2016.

Epigenetics is an area of developmental biology that involves the study of cellular and physiological trait variations initiated by external or ecological aspects. This external stimulus swipe genes on and off and affect the ability of cells to read genes. Epigenetics changes the organisms phenotype rather than the genotype, wherein the underlying DNA or RNA sequence remains unchanged. For instance, DNA methylation and histone modification are epigenetic processes wherein the alteration in gene expression is observed without the change in the DNA sequence. The increase in usage and application of epigenetics to formulate drugs to treat different oncology and non-oncology related diseases is expected to boost the market growth.

The major factors that drive the global epigenetics market are rise in cancer prevalence; improved funding & aids for R&D activities, surge in partnership between academic, pharmaceutical, and biotechnology companies, and increased application of epigenetics in non-oncology diseases. However, high cost of instruments and lack of trained professionals are factors that impede the growth of this market. Furthermore, untapped potential of emerging markets provides lucrative opportunities to the market players.

The kits & assays product segment occupies the highest share in epigenetics product market, owing to their sheer usage and need throughout the protocol and other pre-requisite steps of DNA analysis. The next-generation sequencers segment witnessed the highest growth rate, and accounted for over half of the total share in 2016, and is anticipated to dominate the market. This is attributed to most of the epigenetic investigations that utilize this technology to achieve their desired objective.

At present, oncology dominates the application segment and is expected to grow at a CAGR of 12.8% during the forecast period. Drugs based on epigenetics are reported to be incredibly effective and aid reverse abnormal gene expression. Abnormal gene expression causes an array of different diseases, especially cancer and respiratory diseases.

Key Findings of the Epigenetics Market:

The kit & assays product segment is anticipated to grow at the highest CAGR from 2017 to 2023.
The oncology application segment is expected to witness the highest growth rate during the forecast period.
The academic & government research institutes segment generated the highest revenue in 2016, and is expected to continue its dominance in the near future.
North America dominated the global epigenetics market, and is projected to grow at a CAGR of 12.3%.
Asia-Pacific is expected to witness the highest growth rate during the forecast period.

The major companies profiled in the report include Abcam plc., Illumina, QIAGEN N.V., Merck & Co., New England Biolabs, Inc., Sigma-Aldrich Corporation, Thermo Fisher Scientific, Inc., Active Motif. Diagenode, Inc., and Zymo Research Corporation.
Note: Product cover images may vary from those shown
5 of 7
-  Abcam
-  Active Motif
-  Diagenode
-  Illumina
-  Merck
-  New England Biolabs
-  Qiagen
-  Sigma-Aldrich Corporation
-  Thermo Fisher Scientific
-  Zymo Research
Note: Product cover images may vary from those shown
6 of 7
The methodology is available for download below.
7 of 7
Note: Product cover images may vary from those shown
Adroll
adroll